Overview of epidemiology, diagnosis, and disease progression associated with hepatitis C

Area of Science:

• Hepatology
• Infectious Diseases
• Public Health

Background:

• Hepatitis C virus (HCV) affects approximately 3% of the global population, contributing significantly to disease and death.
• A notable knowledge gap exists regarding HCV among healthcare providers and patients, hindering effective management.
• Limited access to diagnosis and treatment is a primary obstacle to improving patient outcomes.

Purpose of the Study:

• To highlight the critical need for enhanced education on Hepatitis C virus (HCV) for both healthcare professionals and patients.
• To emphasize the importance of understanding HCV risk factors for accurate diagnosis and timely treatment initiation.
• To underscore the necessity for clinicians to comprehend factors influencing HCV disease progression for tailored treatment strategies.

Main Methods:

• Literature review on current HCV knowledge gaps and treatment access barriers.
• Analysis of factors influencing HCV diagnosis and disease progression.
• Synthesis of educational needs for clinicians and patients regarding HCV.

Main Results:

• Significant lack of awareness and knowledge about HCV risk factors and disease progression exists.
• Access to timely diagnosis and treatment for HCV is severely limited.
• Effective management of HCV requires comprehensive understanding from diagnosis through to treatment guidance.

Conclusions:

• Educational interventions are essential to bridge the knowledge gap concerning Hepatitis C virus (HCV).
• Improving access to diagnosis and treatment is paramount for mitigating HCV's impact.
• Clinician and patient education on risk factors and disease progression is key to achieving better HCV treatment outcomes.